FEATURED ARTICLES
Don't Accept This Site-Level Start-Up Bottleneck— Instead, Learn How To Stop It
Combining investigator meetings and SIVs can cut site activation timelines in half — if sponsors build a compliance-sound case and involve QA early.
-
![woman receiving cancer treatment-GettyImages-1346190289]( "The Promise Of Bispecifics In The Quest For Outpatient Immunotherapy")
The Promise Of Bispecifics In The Quest For Outpatient ImmunotherapySTART San Antonio's Drew Rasco, MD, reflects on the evolution of immunotherapy and highlights how novel therapies such as bispecifics are both challenging and intriguing for principal investigators (PIs).
-
![commercial comparison-GettyImages-912367618]( "The Profit Margin Double Standard That Needs To Change")
The Profit Margin Double Standard That Needs To ChangeWe expect pharmaceutical companies to have sizable profit margins, but we collectively scoff at research sites for achieving the same. Maria P. Ladd explores this difference in expectations and why it needs to change for the sake of the industry.
-
![AMRC series 3]( "Why The Governed Hybrid Site Model Is Strategically Superior — Part 3")
Why The Governed Hybrid Site Model Is Strategically Superior — Part 3In the third and final part of this series, Paradigm Clinical Research CEO Kurt Mussina, who's become an advocate for the governed hybrid platform, explains why he believes it's the best fit for sponsors.
SERVICES & PRODUCTS
Accelerate trials with a centralized digital workspace that replaces manual documents, boosts collaboration, supports remote access, ensures compliance, and provides real-time visibility.
People-focused, detail-driven (and award-winning!) support for participants, sites, and sponsors.
Scout’s patient concierge team manages payments, travel, and scheduling with precision and empathy—helping sites save time, build trust, and reduce dropouts.
Flexibility matters. Scout helps you plan hybrid and virtual meetings that connect global teams and keep every attendee engaged.
Whether in-person, online, or both, our hybrid meeting solutions for clinical trials make collaboration simple, secure, and human.
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
In clinical trials, the patient is the site’s customer — but the site is the CRO’s customer. That’s why we’ve redefined site management and clinical monitoring, merging comprehensive oversight with streamlined efficiency
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.